Michael T. Lotze - Publications

University of Pittsburgh, Pittsburgh, PA, United States 
Cell Biology, Immunology, Genetics, Oncology

228 high-probability publications. We are testing a new system for linking publications to authors. You can help! If you notice any inaccuracies, please sign in and mark papers as correct or incorrect matches. If you identify any major omissions or other inaccuracies in the publication list, please let us know.

Year Citation  Score
2020 Galluzzi L, Vitale I, Warren S, Adjemian S, Agostinis P, Martinez AB, Chan TA, Coukos G, Demaria S, Deutsch E, Draganov D, Edelson RL, Formenti SC, Fucikova J, Gabriele L, ... ... Lotze MT, et al. Consensus guidelines for the definition, detection and interpretation of immunogenic cell death. Journal For Immunotherapy of Cancer. 8. PMID 32209603 DOI: 10.1136/jitc-2019-000337  0.36
2020 Zeh H, Bahary N, Boone BA, Singhi AD, Miller-Ocuin JL, Normolle DP, Zureikat AH, Hogg ME, Bartlett DL, Lee KK, Tsung A, Marsh JW, Murthy P, Tang D, Seiser N, ... ... Lotze MT, et al. A Randomized Phase II Preoperative Study of Autophagy Inhibition With High-Dose Hydroxychloroquine and Gemcitabine/Nab-Paclitaxel in Pancreatic Cancer Patients. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. PMID 32156749 DOI: 10.1158/1078-0432.CCR-19-4042  0.36
2019 Murthy P, Zenati MS, Al Abbas AI, Rieser CJ, Bahary N, Lotze MT, Zeh HJ, Zureikat AH, Boone BA. Prognostic Value of the Systemic Immune-Inflammation Index (SII) After Neoadjuvant Therapy for Patients with Resected Pancreatic Cancer. Annals of Surgical Oncology. PMID 31792715 DOI: 10.1245/s10434-019-08094-0  0.36
2019 Miller-Ocuin JL, Liang X, Boone BA, Doerfler WR, Singhi AD, Tang D, Kang R, Lotze MT, Zeh HJ. DNA released from neutrophil extracellular traps (NETs) activates pancreatic stellate cells and enhances pancreatic tumor growth. Oncoimmunology. 8: e1605822. PMID 31428515 DOI: 10.1080/2162402X.2019.1605822  0.36
2019 Yang M, Chen P, Liu J, Zhu S, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. Clockophagy is a novel selective autophagy process favoring ferroptosis. Science Advances. 5: eaaw2238. PMID 31355331 DOI: 10.1126/sciadv.aaw2238  0.36
2019 Li G, Sachdev U, Peters K, Liang X, Lotze MT. The VE-PTP Inhibitor AKB-9778 Improves Antitumor Activity and Diminishes the Toxicity of Interleukin 2 (IL-2) Administration. Journal of Immunotherapy (Hagerstown, Md. : 1997). PMID 31348125 DOI: 10.1097/CJI.0000000000000290  0.36
2019 Boone BA, Murthy P, Miller-Ocuin JL, Liang X, Russell KL, Loughran P, Gawaz M, Lotze MT, Zeh HJ, Vogel S. The platelet NLRP3 inflammasome is upregulated in a murine model of pancreatic cancer and promotes platelet aggregation and tumor growth. Annals of Hematology. PMID 31020347 DOI: 10.1007/s00277-019-03692-0  0.36
2019 Murthy P, Singhi AD, Ross MA, Loughran P, Paragomi P, Papachristou GI, Whitcomb DC, Zureikat AH, Lotze MT, Zeh Iii HJ, Boone BA. Enhanced Neutrophil Extracellular Trap Formation in Acute Pancreatitis Contributes to Disease Severity and Is Reduced by Chloroquine. Frontiers in Immunology. 10: 28. PMID 30733719 DOI: 10.3389/fimmu.2019.00028  1
2019 Vogel S, Murthy P, Cui X, Lotze MT, Zeh HJ, Sachdev U. TLR4-dependent upregulation of the platelet NLRP3 inflammasome promotes platelet aggregation in a murine model of hindlimb ischemia. Biochemical and Biophysical Research Communications. 508: 614-619. PMID 30522866 DOI: 10.1016/j.bbrc.2018.11.125  0.36
2018 Li C, Zhang Y, Cheng X, Yuan H, Zhu S, Liu J, Wen Q, Xie Y, Liu J, Kroemer G, Klionsky DJ, Lotze MT, Zeh HJ, Kang R, Tang D. PINK1 and PARK2 Suppress Pancreatic Tumorigenesis through Control of Mitochondrial Iron-Mediated Immunometabolism. Developmental Cell. PMID 30100261 DOI: 10.1016/j.devcel.2018.07.012  0.36
2018 Song X, Zhu S, Chen P, Hou W, Wen Q, Liu J, Xie Y, Liu J, Klionsky DJ, Kroemer G, Lotze MT, Zeh HJ, Kang R, Tang D. AMPK-Mediated BECN1 Phosphorylation Promotes Ferroptosis by Directly Blocking System X Activity. Current Biology : Cb. PMID 30057310 DOI: 10.1016/j.cub.2018.05.094  0.36
2018 Boone BA, Murthy P, Miller-Ocuin J, Doerfler WR, Ellis JT, Liang X, Ross MA, Wallace CT, Sperry JL, Lotze MT, Neal MD, Zeh HJ. Chloroquine reduces hypercoagulability in pancreatic cancer through inhibition of neutrophil extracellular traps. Bmc Cancer. 18: 678. PMID 29929491 DOI: 10.1186/s12885-018-4584-2  0.36
2018 Anunobi R, Boone BA, Cheh N, Tang D, Kang R, Loux T, Lotze MT, Zeh HJ. Extracellular DNA promotes colorectal tumor cell survival after cytotoxic chemotherapy. The Journal of Surgical Research. PMID 29605400 DOI: 10.1016/j.jss.2018.02.042  0.36
2018 Kim HY, Wang X, Kang R, Tang D, Boone BA, Zeh HJ, Lotze MT, Edwards WB. RAGE-specific single chain Fv for PET imaging of pancreatic cancer. Plos One. 13: e0192821. PMID 29529089 DOI: 10.1371/journal.pone.0192821  0.36
2017 Song X, Zhu S, Xie Y, Liu J, Sun L, Zeng D, Wang P, Ma X, Kroemer G, Bartlett DL, Billiar TR, Lotze M, Zeh H, Kang R, Tang D. JTC801 Induces pH-dependent Death Specifically in Cancer Cells and Slows Growth of Tumors in Mice. Gastroenterology. PMID 29248440 DOI: 10.1053/j.gastro.2017.12.004  0.36
2017 Chen R, Zhu S, Fan XG, Wang H, Lotze MT, Zeh HJ, Billiar TR, Kang R, Tang D. HMGB1 Controls Liver Cancer Initiation through YAP-dependent Aerobic Glycolysis. Hepatology (Baltimore, Md.). PMID 29149457 DOI: 10.1002/hep.29663  0.36
2017 Xie Y, Zhu S, Song X, Sun X, Fan Y, Liu J, Zhong M, Yuan H, Zhang L, Billiar TR, Lotze MT, Zeh HJ, Kang R, Kroemer G, Tang D. The Tumor Suppressor p53 Limits Ferroptosis by Blocking DPP4 Activity. Cell Reports. 20: 1692-1704. PMID 28813679 DOI: 10.1016/j.celrep.2017.07.055  0.36
2017 Xie Y, Zhu S, Zhong M, Yang M, Sun X, Liu J, Kroemer G, Lotze M, Zeh HJ, Kang R, Tang D. Inhibition of Aurora Kinase A Induces Necroptosis in Pancreatic Carcinoma. Gastroenterology. PMID 28764929 DOI: 10.1053/j.gastro.2017.07.036  0.36
2017 Kang R, Xie Y, Zhang Q, Hou W, Jiang Q, Zhu S, Liu J, Zeng D, Wang H, Bartlett DL, Billiar TR, Zeh HJ, Lotze MT, Tang D. Intracellular HMGB1 as a novel tumor suppressor of pancreatic cancer. Cell Research. PMID 28374746 DOI: 10.1038/cr.2017.51  0.36
2017 Zhu S, Zhang Q, Sun X, Zeh HJ, Lotze MT, Kang R, Tang D. HSPA5 Regulates Ferroptotic Cell Death in Cancer Cells. Cancer Research. PMID 28130223 DOI: 10.1158/0008-5472.CAN-16-1979  0.36
2016 Murthy P, Durco F, Miller-Ocuin JL, Takedai T, Shankar S, Liang X, Liu X, Cui X, Sachdev U, Rath D, Lotze MT, Zeh HJ, Gawaz M, Weber AN, Vogel S. The NLRP3 inflammasome and bruton's tyrosine kinase in platelets co-regulate platelet activation, aggregation, and in vitro thrombus formation. Biochemical and Biophysical Research Communications. PMID 28034752 DOI: 10.1016/j.bbrc.2016.12.161  0.36
2016 Van Der Kraak L, Goel G, Ramanan K, Kaltenmeier C, Zhang L, Normolle DP, Freeman GJ, Tang D, Nason KS, Davison JM, Luketich JD, Dhupar R, Lotze MT. 5-Fluorouracil upregulates cell surface B7-H1 (PD-L1) expression in gastrointestinal cancers. Journal For Immunotherapy of Cancer. 4: 65. PMID 27777774 DOI: 10.1186/s40425-016-0163-8  0.36
2016 Chen R, Xie Y, Zhong X, Fu Y, Huang Y, Zhen Y, Pan P, Wang H, Bartlett DL, Billiar TR, Lotze MT, Zeh Iii HJ, Fan XG, Tang D, Kang R. Novel chemokine-like activities of histones in tumor metastasis. Oncotarget. PMID 27623211 DOI: 10.18632/oncotarget.11226  1
2016 Hou W, Xie Y, Song X, Sun X, Lotze MT, Zeh HJ, Kang R, Tang D. Autophagy Promotes Ferroptosis by Degradation of Ferritin. Autophagy. 0. PMID 27245739 DOI: 10.1080/15548627.2016.1187366  0.36
2016 Kang R, Chen R, Xie M, Cao L, Lotze MT, Tang D, Zeh HJ. The Receptor for Advanced Glycation End Products Activates the AIM2 Inflammasome in Acute Pancreatitis. Journal of Immunology (Baltimore, Md. : 1950). PMID 27045109 DOI: 10.4049/jimmunol.1502340  0.36
2016 Xie Y, Song X, Sun X, Huang J, Zhong M, Lotze MT, Zeh HJ, Kang R, Tang D. Identification of baicalein as a ferroptosis inhibitor by natural product library screening. Biochemical and Biophysical Research Communications. PMID 27037021 DOI: 10.1016/j.bbrc.2016.03.052  0.36
2015 Yu Y, Xie Y, Cao L, Yang L, Yang M, Lotze MT, Zeh HJ, Kang R, Tang D. The ferroptosis inducer erastin enhances sensitivity of acute myeloid leukemia cells to chemotherapeutic agents. Molecular & Cellular Oncology. 2: e1054549. PMID 27308510 DOI: 10.1080/23723556.2015.1054549  0.36
2015 Boone BA, Orlichenko L, Schapiro NE, Loughran P, Gianfrate GC, Ellis JT, Singhi AD, Kang R, Tang D, Lotze MT, Zeh HJ. The receptor for advanced glycation end products (RAGE) enhances autophagy and neutrophil extracellular traps in pancreatic cancer. Cancer Gene Therapy. 22: 326-34. PMID 25908451 DOI: 10.1038/cgt.2015.21  1
2015 Boone BA, Bahary N, Zureikat AH, Moser AJ, Normolle DP, Wu WC, Singhi AD, Bao P, Bartlett DL, Liotta LA, Espina V, Loughran P, Lotze MT, Zeh HJ. Safety and Biologic Response of Pre-operative Autophagy Inhibition in Combination with Gemcitabine in Patients with Pancreatic Adenocarcinoma. Annals of Surgical Oncology. PMID 25905586 DOI: 10.1245/s10434-015-4566-4  1
2015 Shakir M, Tang D, Zeh HJ, Tang SW, Anderson CJ, Bahary N, Lotze MT. The chemokine receptors CXCR4/CXCR7 and their primary heterodimeric ligands CXCL12 and CXCL12/high mobility group box 1 in pancreatic cancer growth and development: finding flow. Pancreas. 44: 528-34. PMID 25872129 DOI: 10.1097/MPA.0000000000000298  1
2015 Chen M, Liu Y, Varley P, Chang Y, He XX, Huang H, Tang D, Lotze MT, Lin J, Tsung A. High-Mobility Group Box 1 Promotes Hepatocellular Carcinoma Progression through miR-21-Mediated Matrix Metalloproteinase Activity. Cancer Research. 75: 1645-56. PMID 25720799 DOI: 10.1158/0008-5472.CAN-14-2147  0.36
2015 Chen R, Fu S, Fan XG, Lotze MT, Zeh HJ, Tang D, Kang R. Nuclear DAMP complex-mediated RAGE-dependent macrophage cell death. Biochemical and Biophysical Research Communications. 458: 650-5. PMID 25684181 DOI: 10.1016/j.bbrc.2015.01.159  0.36
2015 Liu Y, Yan W, Tohme S, Chen M, Fu Y, Tian D, Lotze M, Tang D, Tsung A. Hypoxia induced HMGB1 and mitochondrial DNA interactions mediate tumor growth in hepatocellular carcinoma through Toll-like receptor 9. Journal of Hepatology. 63: 114-21. PMID 25681553 DOI: 10.1016/j.jhep.2015.02.009  0.36
2015 Zhu X, Messer JS, Wang Y, Lin F, Cham CM, Chang J, Billiar TR, Lotze MT, Boone DL, Chang EB. Cytosolic HMGB1 controls the cellular autophagy/apoptosis checkpoint during inflammation. The Journal of Clinical Investigation. 125: 1098-110. PMID 25642769 DOI: 10.1172/JCI76344  1
2015 Sehgal AR, Konig H, Johnson DE, Tang D, Amaravadi RK, Boyiadzis M, Lotze MT. You eat what you are: autophagy inhibition as a therapeutic strategy in leukemia. Leukemia. 29: 517-25. PMID 25541151 DOI: 10.1038/leu.2014.349  0.36
2014 Huang J, Xie Y, Sun X, Zeh HJ, Kang R, Lotze MT, Tang D. DAMPs, ageing, and cancer: The 'DAMP Hypothesis' Ageing Research Reviews. PMID 25446804 DOI: 10.1016/j.arr.2014.10.004  0.36
2014 Kang R, Hou W, Zhang Q, Chen R, Lee YJ, Bartlett DL, Lotze MT, Tang D, Zeh HJ. RAGE is essential for oncogenic KRAS-mediated hypoxic signaling in pancreatic cancer. Cell Death & Disease. 5: e1480. PMID 25341034 DOI: 10.1038/cddis.2014.445  0.36
2014 Kang R, Lotze MT, Zeh HJ, Billiar TR, Tang D. Cell death and DAMPs in acute pancreatitis. Molecular Medicine (Cambridge, Mass.). 20: 466-77. PMID 25105302 DOI: 10.2119/molmed.2014.00117  0.36
2014 Yang L, Xie M, Yang M, Yu Y, Zhu S, Hou W, Kang R, Lotze MT, Billiar TR, Wang H, Cao L, Tang D. PKM2 regulates the Warburg effect and promotes HMGB1 release in sepsis. Nature Communications. 5: 4436. PMID 25019241 DOI: 10.1038/ncomms5436  0.36
2014 Kang R, Chen R, Zhang Q, Hou W, Wu S, Cao L, Huang J, Yu Y, Fan XG, Yan Z, Sun X, Wang H, Wang Q, Tsung A, Billiar TR, ... ... Lotze MT, et al. HMGB1 in health and disease. Molecular Aspects of Medicine. 40: 1-116. PMID 25010388 DOI: 10.1016/j.mam.2014.05.001  0.36
2014 Tang D, Kang R, Van Houten B, Zeh HJ, Billiar TR, Lotze MT. High mobility group box 1 (HMGB1) phenotypic role revealed with stress. Molecular Medicine (Cambridge, Mass.). 20: 359-62. PMID 24937773 DOI: 10.2119/molmed.2014.00063  1
2014 Kang R, Zhang Q, Hou W, Yan Z, Chen R, Bonaroti J, Bansal P, Billiar TR, Tsung A, Wang Q, Bartlett DL, Whitcomb DC, Chang EB, Zhu X, Wang H, ... ... Lotze MT, et al. Intracellular Hmgb1 inhibits inflammatory nucleosome release and limits acute pancreatitis in mice. Gastroenterology. 146: 1097-107. PMID 24361123 DOI: 10.1053/j.gastro.2013.12.015  0.36
2014 Kang R, Tang D, Schapiro NE, Loux T, Livesey KM, Billiar TR, Wang H, Van Houten B, Lotze MT, Zeh HJ. The HMGB1/RAGE inflammatory pathway promotes pancreatic tumor growth by regulating mitochondrial bioenergetics. Oncogene. 33: 567-77. PMID 23318458 DOI: 10.1038/onc.2012.631  0.36
2013 Hou W, Zhang Q, Yan Z, Chen R, Zeh Iii HJ, Kang R, Lotze MT, Tang D. Strange attractors: DAMPs and autophagy link tumor cell death and immunity. Cell Death & Disease. 4: e966. PMID 24336086 DOI: 10.1038/cddis.2013.493  1
2013 Li G, Tang D, Lotze MT. Ménage à Trois in stress: DAMPs, redox and autophagy Seminars in Cancer Biology. 23: 380-390. PMID 23994764 DOI: 10.1016/j.semcancer.2013.08.002  1
2013 Tang S, Bonaroti J, Unlu S, Liang X, Tang D, Zeh HJ, Lotze MT. Sweating the small stuff: MicroRNAs and genetic changes define pancreatic cancer Pancreas. 42: 740-759. PMID 23774697 DOI: 10.1097/MPA.0b013e3182854ab0  1
2013 Vernon PJ, Zeh Iii HJ, Lotze MT. The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products. Oncoimmunology. 2: e24184. PMID 23762800 DOI: 10.4161/onci.24184  1
2013 Kang R, Zhang Q, Zeh HJ, Lotze MT, Tang D. HMGB1 in cancer: good, bad, or both? Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 19: 4046-57. PMID 23723299 DOI: 10.1158/1078-0432.CCR-13-0495  0.36
2013 Li G, Liang X, Lotze MT. HMGB1: The Central Cytokine for All Lymphoid Cells. Frontiers in Immunology. 4: 68. PMID 23519706 DOI: 10.3389/fimmu.2013.00068  0.36
2013 Zhang Q, Kang R, Zeh HJ, Lotze MT, Tang D. DAMPs and autophagy: cellular adaptation to injury and unscheduled cell death. Autophagy. 9: 451-8. PMID 23388380 DOI: 10.4161/auto.23691  0.36
2013 Guo ZS, Liu Z, Bartlett DL, Tang D, Lotze MT. Life after death: targeting high mobility group box 1 in emergent cancer therapies. American Journal of Cancer Research. 3: 1-20. PMID 23359863  0.36
2013 Vernon PJ, Loux TJ, Schapiro NE, Kang R, Muthuswamy R, Kalinski P, Tang D, Lotze MT, Zeh HJ. The receptor for advanced glycation end products promotes pancreatic carcinogenesis and accumulation of myeloid-derived suppressor cells. Journal of Immunology (Baltimore, Md. : 1950). 190: 1372-9. PMID 23269246 DOI: 10.4049/jimmunol.1201151  1
2013 Kang R, Tang D, Lotze MT, Zeh Iii HJ. Autophagy is required for IL-2-mediated fibroblast growth. Experimental Cell Research. 319: 556-65. PMID 23195496 DOI: 10.1016/j.yexcr.2012.11.012  0.36
2013 Vernon PJ, Zeh HJ, Lotze MT. The myeloid response to pancreatic carcinogenesis is regulated by the receptor for advanced glycation end-products Oncoimmunology. 2. DOI: 10.4161/onci.24184  1
2013 Li G, Liang X, Lotze MT. HMGB1: The central cytokine for all lymphoid cells Frontiers in Immunology. 4. DOI: 10.3389/fimmu.2013.00068  1
2013 Lotze MT, Maranchie J, Appleman L. Inhibiting autophagy: A novel approach for the treatment of renal cell carcinoma Cancer Journal (United States). 19: 341-347. DOI: 10.1097/PPO.0b013e31829da0d6  1
2012 Tang D, Billiar TR, Lotze MT. A Janus tale of two active high mobility group box 1 (HMGB1) redox states Molecular Medicine. 18: 1360-1362. PMID 23073660 DOI: 10.2119/molmed.2012.00314  0.36
2012 Tang S, Lotze MT. The power of negative thinking: Which cells limit tumor immunity? Clinical Cancer Research. 18: 5157-5159. PMID 22912390 DOI: 10.1158/1078-0432.CCR-12-2418  1
2012 Tang D, Lotze MT. Tumor immunity times out: TIM-3 and HMGB1 Nature Immunology. 13: 808-810. PMID 22910384 DOI: 10.1038/ni.2396  1
2012 Tang D, Kang R, Coyne CB, Zeh HJ, Lotze MT. PAMPs and DAMPs: signal 0s that spur autophagy and immunity. Immunological Reviews. 249: 158-75. PMID 22889221 DOI: 10.1111/j.1600-065X.2012.01146.x  0.36
2012 Ferris RL, Lotze MT, Leong SPL, Hoon DSB, Morton DL. Lymphatics, lymph nodes and the immune system: Barriers and gateways for cancer spread Clinical and Experimental Metastasis. 29: 729-736. PMID 22851005 DOI: 10.1007/s10585-012-9520-2  1
2012 Unlu S, Tang S, Wang E, Wang En, Martinez I, Tang D, Bianchi ME, Zeh HJ, Lotze MT. Damage associated molecular pattern molecule-induced microRNAs (DAMPmiRs) in human peripheral blood mononuclear cells. Plos One. 7: e38899. PMID 22745684 DOI: 10.1371/journal.pone.0038899  1
2012 Kang R, Tang D, Lotze MT, Zeh HJ. AGER/RAGE-mediated autophagy promotes pancreatic tumorigenesis and bioenergetics through the IL6-pSTAT3 pathway. Autophagy. 8: 989-91. PMID 22722139 DOI: 10.4161/auto.20258  1
2012 Lotze MT, Buchser WJ, Liang X. Blocking the interleukin 2 (IL2)-induced systemic autophagic syndrome promotes profound antitumor effects and limits toxicity. Autophagy. 8: 1264-6. PMID 22660171 DOI: 10.4161/auto.20752  1
2012 Livesey KM, Kang R, Zeh HJ, Lotze MT, Tang D. Direct molecular interactions between HMGB1 and TP53 in colorectal cancer. Autophagy. 8: 846-8. PMID 22647615 DOI: 10.4161/auto.19891  1
2012 Yu Y, Cao L, Yang L, Kang R, Lotze M, Tang D. microRNA 30A promotes autophagy in response to cancer therapy. Autophagy. 8: 853-5. PMID 22617440 DOI: 10.4161/auto.20053  0.36
2012 Kang R, Loux T, Tang D, Schapiro NE, Vernon P, Livesey KM, Krasinskas A, Lotze MT, Zeh HJ. The expression of the receptor for advanced glycation endproducts (RAGE) is permissive for early pancreatic neoplasia. Proceedings of the National Academy of Sciences of the United States of America. 109: 7031-6. PMID 22509024 DOI: 10.1073/pnas.1113865109  1
2012 Buchser WJ, Laskow TC, Pavlik PJ, Lin HM, Lotze MT. Cell-mediated autophagy promotes cancer cell survival. Cancer Research. 72: 2970-9. PMID 22505650 DOI: 10.1158/0008-5472.CAN-11-3396  1
2012 Liang X, De Vera ME, Buchser WJ, Romo de Vivar Chavez A, Loughran P, Beer Stolz D, Basse P, Wang T, Van Houten B, Zeh HJ, Lotze MT. Inhibiting systemic autophagy during interleukin 2 immunotherapy promotes long-term tumor regression. Cancer Research. 72: 2791-801. PMID 22472122 DOI: 10.1158/0008-5472.CAN-12-0320  1
2012 Weiner LM, Lotze MT. Tumor-cell death, autophagy, and immunity. The New England Journal of Medicine. 366: 1156-8. PMID 22435376 DOI: 10.1056/NEJMcibr1114526  1
2012 Livesey KM, Kang R, Vernon P, Buchser W, Loughran P, Watkins SC, Zhang L, Manfredi JJ, Zeh HJ, Li L, Lotze MT, Tang D. p53/HMGB1 complexes regulate autophagy and apoptosis. Cancer Research. 72: 1996-2005. PMID 22345153 DOI: 10.1158/0008-5472.CAN-11-2291  1
2012 Yan W, Chang Y, Liang X, Cardinal JS, Huang H, Thorne SH, Monga SP, Geller DA, Lotze MT, Tsung A. High-mobility group box 1 activates caspase-1 and promotes hepatocellular carcinoma invasiveness and metastases. Hepatology (Baltimore, Md.). 55: 1863-75. PMID 22234969 DOI: 10.1002/hep.25572  1
2011 Lotze MT. Pancreatic cancer is not noble Journal of Innate Immunity. 4: 4-5. PMID 22086192 DOI: 10.1159/000334593  1
2011 Kang R, Livesey KM, Zeh HJ, Lotze MT, Tang D. Metabolic regulation by HMGB1-mediated autophagy and mitophagy. Autophagy. 7: 1256-8. PMID 21691146 DOI: 10.4161/auto.7.10.16753  1
2011 Tang D, Kang R, Livesey KM, Kroemer G, Billiar TR, Van Houten B, Zeh HJ, Lotze MT. High-mobility group box 1 is essential for mitochondrial quality control. Cell Metabolism. 13: 701-11. PMID 21641551 DOI: 10.1016/j.cmet.2011.04.008  1
2011 Kang R, Livesey KM, Zeh HJ, Lotze MT, Tang D. HMGB1 as an autophagy sensor in oxidative stress. Autophagy. 7: 904-6. PMID 21487246 DOI: 10.4161/auto.7.8.15704  1
2011 Tang D, Kang R, Livesey KM, Zeh HJ, Lotze MT. High mobility group box 1 (HMGB1) activates an autophagic response to oxidative stress. Antioxidants & Redox Signaling. 15: 2185-95. PMID 21395369 DOI: 10.1089/ars.2010.3666  1
2011 Wong JL, Mailliard RB, Moschos SJ, Edington H, Lotze MT, Kirkwood JM, Kalinski P. Helper activity of natural killer cells during the dendritic cell-mediated induction of melanoma-specific cytotoxic T cells. Journal of Immunotherapy (Hagerstown, Md. : 1997). 34: 270-8. PMID 21389871 DOI: 10.1097/CJI.0b013e31820b370b  1
2011 Amaravadi RK, Lippincott-Schwartz J, Yin XM, Weiss WA, Takebe N, Timmer W, DiPaola RS, Lotze MT, White E. Principles and current strategies for targeting autophagy for cancer treatment. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 17: 654-66. PMID 21325294 DOI: 10.1158/1078-0432.CCR-10-2634  1
2011 Kang R, Tang D, Lotze MT, Zeh HJ. RAGE regulates autophagy and apoptosis following oxidative injury. Autophagy. 7: 442-4. PMID 21317562 DOI: 10.4161/auto.7.4.14681  1
2011 Kang R, Zeh HJ, Lotze MT, Tang D. The Beclin 1 network regulates autophagy and apoptosis. Cell Death and Differentiation. 18: 571-80. PMID 21311563 DOI: 10.1038/cdd.2010.191  0.36
2011 Tang D, Lotze MT, Kang R, Zeh HJ. Apoptosis promotes early tumorigenesis. Oncogene. 30: 1851-4. PMID 21151175 DOI: 10.1038/onc.2010.573  0.36
2011 Kang R, Tang D, Livesey KM, Schapiro NE, Lotze MT, Zeh HJ. The Receptor for Advanced Glycation End-products (RAGE) protects pancreatic tumor cells against oxidative injury. Antioxidants & Redox Signaling. 15: 2175-84. PMID 21126167 DOI: 10.1089/ars.2010.3378  1
2011 Kang R, Tang D, Loze MT, Zeh HJ. Apoptosis to autophagy switch triggered by the MHC class III-encoded receptor for advanced glycation endproducts (RAGE). Autophagy. 7: 91-3. PMID 20978368 DOI: 10.1038/cdd.2009.149  1
2011 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1, oxidative stress, and disease. Antioxidants & Redox Signaling. 14: 1315-35. PMID 20969478 DOI: 10.1089/ars.2010.3356  1
2011 Liu L, Yang M, Kang R, Wang Z, Zhao Y, Yu Y, Xie M, Yin X, Livesey KM, Lotze MT, Tang D, Cao L. HMGB1-induced autophagy promotes chemotherapy resistance in leukemia cells. Leukemia. 25: 23-31. PMID 20927132 DOI: 10.1038/leu.2010.225  0.36
2010 John E, Laskow TC, Buchser WJ, Pitt BR, Basse PH, Butterfield LH, Kalinski P, Lotze MT. Zinc in innate and adaptive tumor immunity. Journal of Translational Medicine. 8: 118. PMID 21087493 DOI: 10.1186/1479-5876-8-118  1
2010 Tang D, Kang R, Livesey KM, Cheh CW, Farkas A, Loughran P, Hoppe G, Bianchi ME, Tracey KJ, Zeh HJ, Lotze MT. Endogenous HMGB1 regulates autophagy. The Journal of Cell Biology. 190: 881-92. PMID 20819940 DOI: 10.1083/jcb.200911078  1
2010 Sun LT, Buchholz KS, Lotze MT, Washburn NR. Cytokine binding by polysaccharide-antibody conjugates. Molecular Pharmaceutics. 7: 1769-77. PMID 20726535 DOI: 10.1021/mp100150z  1
2010 Lesinski GB, Carson WE, Repasky EA, Wei WZ, Kalinski P, Lotze MT, June CH, Petros W, Muthusamy N, Olencki T. Meeting report: The 13th Annual Meeting of the Translational Research Cancer Centers Consortium (TrC3); Immune Suppression and the Tumor Microenvironment, Columbus, Ohio; March 1-2, 2010. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 659-62. PMID 20664361 DOI: 10.1097/CJI.0b013e3181eccbf7  1
2010 Tang D, Kang R, Cheh CW, Livesey KM, Liang X, Schapiro NE, Benschop R, Sparvero LJ, Amoscato AA, Tracey KJ, Zeh HJ, Lotze MT. HMGB1 release and redox regulates autophagy and apoptosis in cancer cells. Oncogene. 29: 5299-310. PMID 20622903 DOI: 10.1038/onc.2010.261  1
2010 Yang H, Rivera Z, Jube S, Nasu M, Bertino P, Goparaju C, Franzoso G, Lotze MT, Krausz T, Pass HI, Bianchi ME, Carbone M. Programmed necrosis induced by asbestos in human mesothelial cells causes high-mobility group box 1 protein release and resultant inflammation. Proceedings of the National Academy of Sciences of the United States of America. 107: 12611-6. PMID 20616036 DOI: 10.1073/pnas.1006542107  1
2010 Sun LT, Bencherif SA, Gilbert TW, Lotze MT, Washburn NR. Design principles for cytokine-neutralizing gels: Cross-linking effects. Acta Biomaterialia. 6: 4708-15. PMID 20601239 DOI: 10.1016/j.actbio.2010.06.029  1
2010 Sun LT, Bencherif SA, Gilbert TW, Farkas AM, Lotze MT, Washburn NR. Biological activities of cytokine-neutralizing hyaluronic acid-antibody conjugates. Wound Repair and Regeneration : Official Publication of the Wound Healing Society [and] the European Tissue Repair Society. 18: 302-10. PMID 20412551 DOI: 10.1111/j.1524-475X.2010.00591.x  1
2010 Demaria S, Pikarsky E, Karin M, Coussens LM, Chen YC, El-Omar EM, Trinchieri G, Dubinett SM, Mao JT, Szabo E, Krieg A, Weiner GJ, Fox BA, Coukos G, Wang E, ... ... Lotze MT, et al. Cancer and inflammation: promise for biologic therapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 33: 335-51. PMID 20386472 DOI: 10.1097/CJI.0b013e3181d32e74  1
2010 Sasaki K, Kohanbash G, Hoji A, Ueda R, McDonald HA, Reinhart TA, Martinson J, Lotze MT, Marincola FM, Wang E, Fujita M, Okada H. miR-17-92 expression in differentiated T cells - implications for cancer immunotherapy. Journal of Translational Medicine. 8: 17. PMID 20167088 DOI: 10.1186/1479-5876-8-17  1
2010 Okada H, Kohanbash G, Lotze MT. MicroRNAs in immune regulation-Opportunities for cancer immunotherapy International Journal of Biochemistry and Cell Biology. 42: 1256-1261. PMID 20144731 DOI: 10.1016/j.biocel.2010.02.002  1
2010 Tang D, Kang R, Zeh HJ, Lotze MT. High-mobility group box 1 and cancer. Biochimica Et Biophysica Acta. 1799: 131-40. PMID 20123075 DOI: 10.1016/j.bbagrm.2009.11.014  1
2009 Chavez AR, Buchser W, Basse PH, Liang X, Appleman LJ, Maranchie JK, Zeh H, de Vera ME, Lotze MT. Pharmacologic administration of interleukin-2. Annals of the New York Academy of Sciences. 1182: 14-27. PMID 20074271 DOI: 10.1111/j.1749-6632.2009.05160.x  1
2009 Livesey KM, Tang D, Zeh HJ, Lotze MT. Autophagy inhibition in combination cancer treatment Current Opinion in Investigational Drugs. 10: 1269-1279. PMID 19943199  1
2009 Lotfi R, Herzog GI, DeMarco RA, Beer-Stolz D, Lee JJ, Rubartelli A, Schrezenmeier H, Lotze MT. Eosinophils oxidize damage-associated molecular pattern molecules derived from stressed cells Journal of Immunology. 183: 5023-5031. PMID 19794066 DOI: 10.4049/jimmunol.0900504  1
2009 Tör M, Lotze MT, Holton N. Receptor-mediated signalling in plants: molecular patterns and programmes. Journal of Experimental Botany. 60: 3645-54. PMID 19628572 DOI: 10.1093/jxb/erp233  1
2009 Liang X, Chavez AR, Schapiro NE, Loughran P, Thorne SH, Amoscato AA, Zeh HJ, Beer-Stolz D, Lotze MT, de Vera ME. Ethyl pyruvate administration inhibits hepatic tumor growth. Journal of Leukocyte Biology. 86: 599-607. PMID 19584311 DOI: 10.1189/jlb.0908578  1
2009 Tahara H, Sato M, Thurin M, Wang E, Butterfield LH, Disis ML, Fox BA, Lee PP, Khleif SN, Wigginton JM, Ambs S, Akutsu Y, Chaussabel D, Doki Y, Eremin O, ... ... Lotze MT, et al. Emerging concepts in biomarker discovery; the US-Japan Workshop on Immunological Molecular Markers in Oncology. Journal of Translational Medicine. 7: 45. PMID 19534815 DOI: 10.1186/1479-5876-7-45  1
2009 Ueda R, Kohanbash G, Sasaki K, Fujita M, Zhu X, Kastenhuber ER, McDonald HA, Potter DM, Hamilton RL, Lotze MT, Khan SA, Sobol RW, Okada H. Dicer-regulated microRNAs 222 and 339 promote resistance of cancer cells to cytotoxic T-lymphocytes by down-regulation of ICAM-1. Proceedings of the National Academy of Sciences of the United States of America. 106: 10746-51. PMID 19520829 DOI: 10.1073/pnas.0811817106  1
2009 Cardinal J, Pan P, Dhupar R, Ross M, Nakao A, Lotze M, Billiar T, Geller D, Tsung A. Cisplatin prevents high mobility group box 1 release and is protective in a murine model of hepatic ischemia/reperfusion injury. Hepatology (Baltimore, Md.). 50: 565-74. PMID 19492424 DOI: 10.1002/hep.23021  1
2009 Pan P, Cardinal J, Dhupar R, Rosengart MR, Lotze MT, Geller DA, Billiar TR, Tsung A. Low-dose cisplatin administration in murine cecal ligation and puncture prevents the systemic release of HMGB1 and attenuates lethality Journal of Leukocyte Biology. 86: 625-632. PMID 19487305 DOI: 10.1189/jlb.1108713  1
2009 Davé SH, Tilstra JS, Matsuoka K, Li F, DeMarco RA, Beer-Stolz D, Sepulveda AR, Fink MP, Lotze MT, Plevy SE. Ethyl pyruvate decreases HMGB1 release and ameliorates murine colitis. Journal of Leukocyte Biology. 86: 633-43. PMID 19454652 DOI: 10.1189/jlb.1008662  1
2009 Lee JJ, Lotze MT. Molecular basis of metastasis [8] New England Journal of Medicine. 360: 1679. PMID 19373967  1
2009 Sparvero LJ, Asafu-Adjei D, Kang R, Tang D, Amin N, Im J, Rutledge R, Lin B, Amoscato AA, Zeh HJ, Lotze MT. RAGE (Receptor for Advanced Glycation Endproducts), RAGE ligands, and their role in cancer and inflammation. Journal of Translational Medicine. 7: 17. PMID 19292913 DOI: 10.1186/1479-5876-7-17  1
2009 Lotfi R, Schrezenmeier H, Lotze MT. Immunotherapy for cancer: Promoting innate immunity Frontiers in Bioscience. 14: 818-832. PMID 19273102 DOI: 10.2741/3280  1
2009 Tang D, Kang R, Xiao W, Zhang H, Lotze MT, Wang H, Xiao X. Quercetin prevents LPS-induced high-mobility group box 1 release and proinflammatory function. American Journal of Respiratory Cell and Molecular Biology. 41: 651-60. PMID 19265175 DOI: 10.1165/rcmb.2008-0119OC  1
2009 Romo de Vivar Chavez A, de Vera ME, Liang X, Lotze MT. The biology of interleukin-2 efficacy in the treatment of patients with renal cell carcinoma Medical Oncology (Northwood, London, England). 26: 3-12. PMID 19148593 DOI: 10.1007/s12032-008-9162-z  1
2008 Livesey KM, Tang D, Zeh HJ, Lotze MT. Not just nuclear proteins: 'Novel' autophagy cancer treatment targets - p53 and HMGB1 Current Opinion in Investigational Drugs. 9: 1259-1263. PMID 19037832  1
2008 Moschos SJ, Mandic M, Kirkwood JM, Storkus WJ, Lotze MT. Focus on FOCIS: Interleukin 2 treatment associated autoimmunity Clinical Immunology. 127: 123-129. PMID 18405863 DOI: 10.1016/j.clim.2008.02.011  1
2008 Lotze MT, Nepom GT. A nexus of science and clinical immunology: The Federation of Clinical Immunology Societies and the FOCIS Centers of Excellence Clinical Immunology. 127: 119-120. PMID 18405861 DOI: 10.1016/j.clim.2008.02.010  1
2008 Vakkila J, Demarco RA, Lotze MT. Coordinate NF-κB and STAT1 activation promotes development of myeloid type 1 dendritic cells Scandinavian Journal of Immunology. 67: 260-269. PMID 18261039 DOI: 10.1111/j.1365-3083.2007.02068.x  1
2008 Östberg T, Wähämaa H, Palmblad K, Ito N, Stridh P, Shoshan M, Lotze MT, Harris HE, Andersson U. Oxaliplatin retains HMGB1 intranuclearly and ameliorates collagen type II-induced arthritis Arthritis Research and Therapy. 10. PMID 18179697 DOI: 10.1186/ar2347  1
2008 Lotfi R, Lotze MT. Eosinophils induce DC maturation, regulating immunity Journal of Leukocyte Biology. 83: 456-460. PMID 17991762 DOI: 10.1189/jlb.0607366  1
2008 Zetterström CK, Jiang W, Wähämaa H, Ostberg T, Aveberger AC, Schierbeck H, Lotze MT, Andersson U, Pisetsky DS, Erlandsson Harris H. Pivotal advance: inhibition of HMGB1 nuclear translocation as a mechanism for the anti-rheumatic effects of gold sodium thiomalate. Journal of Leukocyte Biology. 83: 31-8. PMID 17913975 DOI: 10.1189/jlb.0507323  1
2007 Farkas AM, Kilgore TM, Lotze MT. Detecting DNA: getting and begetting cancer. Current Opinion in Investigational Drugs (London, England : 2000). 8: 981-6. PMID 18058568  1
2007 Lotze MT, Zeh HJ, Rubartelli A, Sparvero LJ, Amoscato AA, Washburn NR, Devera ME, Liang X, Tör M, Billiar T. The grateful dead: damage-associated molecular pattern molecules and reduction/oxidation regulate immunity. Immunological Reviews. 220: 60-81. PMID 17979840 DOI: 10.1111/j.1600-065X.2007.00579.x  1
2007 Lotze MT, Gray J. A life in passing: Jonathan Gray. Journal of Translational Medicine. 5: 54. PMID 17971233 DOI: 10.1186/1479-5876-5-54  1
2007 Hikawa H, Lotze MT, Rosenblum WD. Induction of peripheral tolerance by local delivery of dendritic cell progenitors to cardiac allografts in a murine heterotopic heart transplantation model. General Thoracic and Cardiovascular Surgery. 55: 307-14. PMID 17867275 DOI: 10.1007/s11748-007-0133-7  1
2007 Rubartelli A, Lotze MT. Inside, outside, upside down: damage-associated molecular-pattern molecules (DAMPs) and redox. Trends in Immunology. 28: 429-36. PMID 17845865 DOI: 10.1016/j.it.2007.08.004  1
2007 Dong Xda E, Ito N, Lotze MT, Demarco RA, Popovic P, Shand SH, Watkins S, Winikoff S, Brown CK, Bartlett DL, Zeh HJ. High mobility group box I (HMGB1) release from tumor cells after treatment: implications for development of targeted chemoimmunotherapy. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 596-606. PMID 17667523 DOI: 10.1097/CJI.0b013e31804efc76  1
2007 Atkins MB, Carbone D, Coukos G, Dhodapkar M, Ernstoff MS, Finke J, Gajewski TF, Gollob J, Lotze MT, Storkus W, Weiner LM. Report on the ISBTC mini-symposium on biologic effects of targeted therapeutics. Journal of Immunotherapy (Hagerstown, Md. : 1997). 30: 577-90. PMID 17667521 DOI: 10.1097/CJI.0b013e318064e7b2  1
2007 Levy RM, Mollen KP, Prince JM, Kaczorowski DJ, Vallabhaneni R, Liu S, Tracey KJ, Lotze MT, Hackam DJ, Fink MP, Vodovotz Y, Billiar TR. Systemic inflammation and remote organ injury following trauma require HMGB1. American Journal of Physiology. Regulatory, Integrative and Comparative Physiology. 293: R1538-44. PMID 17652366 DOI: 10.1152/ajpregu.00272.2007  1
2007 Ellerman JE, Brown CK, de Vera M, Zeh HJ, Billiar T, Rubartelli A, Lotze MT. Masquerader: high mobility group box-1 and cancer. Clinical Cancer Research : An Official Journal of the American Association For Cancer Research. 13: 2836-48. PMID 17504981 DOI: 10.1158/1078-0432.CCR-06-1953  0.36
2007 Lotze MT, Deisseroth A, Rubartelli A. Damage associated molecular pattern molecules. Clinical Immunology (Orlando, Fla.). 124: 1-4. PMID 17468050 DOI: 10.1016/j.clim.2007.02.006  1
2007 Ito N, DeMarco RA, Mailliard RB, Han J, Rabinowich H, Kalinski P, Stolz DB, Zeh HJ, Lotze MT. Cytolytic cells induce HMGB1 release from melanoma cell lines. Journal of Leukocyte Biology. 81: 75-83. PMID 16968820 DOI: 10.1189/jlb.0306169  0.36
2006 Popovic PJ, DeMarco R, Lotze MT, Winikoff SE, Bartlett DL, Krieg AM, Guo ZS, Brown CK, Tracey KJ, Zeh HJ. High mobility group B1 protein suppresses the human plasmacytoid dendritic cell response to TLR9 agonists. Journal of Immunology (Baltimore, Md. : 1950). 177: 8701-7. PMID 17142771 DOI: 10.4049/JIMMUNOL.177.12.8701  1
2006 Montag DT, Lotze MT. Rapid flow cytometric measurement of cytokine-induced phosphorylation pathways [CIPP] in human peripheral blood leukocytes Clinical Immunology. 121: 215-226. PMID 16959540 DOI: 10.1016/j.clim.2006.06.013  1
2006 Montag DT, Lotze MT. Successful simultaneous measurement of cell membrane and cytokine induced phosphorylation pathways [CIPP] in human peripheral blood mononuclear cells. Journal of Immunological Methods. 313: 48-60. PMID 16716344 DOI: 10.1016/j.jim.2006.03.014  1
2006 D'Aiuto L, De Marco R, Edward N, Rizzo A, Chaillet JR, Montecalvo A, Lotze MT, Gambotto A. Evidence of the capability of the CMV enhancer to activate in trans gene expression in mammalian cells. Dna and Cell Biology. 25: 171-80. PMID 16569196 DOI: 10.1089/dna.2006.25.171  1
2005 Zeh HJ, Winikoff S, Landsittel DP, Gorelik E, Marrangoni AM, Velikokhatnaya L, Winans MT, Lee K, Moser A, Bartlett D, Lotze MT, Siegfried JM, Whitcomb D, Papacristou G, Slivka A, et al. Multianalyte profiling of serum cytokines for detection of pancreatic cancer. Cancer Biomarkers : Section a of Disease Markers. 1: 259-69. PMID 17192050 DOI: 10.3233/CBM-2005-1601  1
2005 Fujii S, Nishimura MI, Lotze MT. Regulatory balance between the immune response of tumor antigen-specific T-cell receptor gene-transduced CD8 T cells and the suppressive effects of tolerogenic dendritic cells. Cancer Science. 96: 897-902. PMID 16367910 DOI: 10.1111/j.1349-7006.2005.00124.x  1
2005 Hauskrecht M, Pelikan R, Malehorn DE, Bigbee WL, Lotze MT, Zeh HJ, Whitcomb DC, Lyons-Weiler J. Feature Selection for Classification of SELDI-TOF-MS Proteomic Profiles. Applied Bioinformatics. 4: 227-46. PMID 16309341 DOI: 10.2165/00822942-200504040-00003  1
2005 Guo ZS, Naik A, O'Malley ME, Popovic P, Demarco R, Hu Y, Yin X, Yang S, Zeh HJ, Moss B, Lotze MT, Bartlett DL. The enhanced tumor selectivity of an oncolytic vaccinia lacking the host range and antiapoptosis genes SPI-1 and SPI-2. Cancer Research. 65: 9991-8. PMID 16267024 DOI: 10.1158/0008-5472.CAN-05-1630  0.36
2005 Kalinski P, Mailliard RB, Giermasz A, Zeh HJ, Basse P, Bartlett DL, Kirkwood JM, Lotze MT, Herberman RB. Natural killer-dendritic cell cross-talk in cancer immunotherapy. Expert Opinion On Biological Therapy. 5: 1303-15. PMID 16197336 DOI: 10.1517/14712598.5.10.1303  0.36
2005 Lotze MT, Tracey KJ. High-mobility group box 1 protein (HMGB1): Nuclear weapon in the immune arsenal Nature Reviews Immunology. 5: 331-342. PMID 15803152 DOI: 10.1038/nri1594  1
2005 Tsung A, Sahai R, Tanaka H, Nakao A, Fink MP, Lotze MT, Yang H, Li J, Tracey KJ, Geller DA, Billiar TR. The nuclear factor HMGB1 mediates hepatic injury after murine liver ischemia-reperfusion. The Journal of Experimental Medicine. 201: 1135-43. PMID 15795240 DOI: 10.1084/jem.20042614  1
2005 Lotze MT, Wang E, Marincola FM, Hanna N, Bugelski PJ, Burns CA, Coukos G, Damle N, Godfrey TE, Howell WM, Panelli MC, Perricone MA, Petricoin EF, Sauter G, Scheibenbogen C, et al. Workshop on cancer biometrics: identifying biomarkers and surrogates of cancer in patients: a meeting held at the Masur Auditorium, National Institutes of Health. Journal of Immunotherapy (Hagerstown, Md. : 1997). 28: 79-119. PMID 15725954 DOI: 10.1097/01.CJI.0000154251.20125.2E  1
2005 Zeh HJ, Lotze MT. Addicted to death: Invasive cancer and the immune response to unscheduled cell death Journal of Immunotherapy. 28: 1-9. PMID 15614039 DOI: 10.1097/00002371-200501000-00001  1
2005 Demarco RA, Fink MP, Lotze MT. Monocytes promote natural killer cell interferon gamma production in response to the endogenous danger signal HMGB1 Molecular Immunology. 42: 433-444. PMID 15607795 DOI: 10.1016/j.molimm.2004.07.023  1
2005 Winikoff SE, Zeh HJ, DeMarco R, Lotze MT. Cytolytic Assays Measuring Immunity: Basic Biology and Clinical Assessment. 343-349. DOI: 10.1016/B978-012455900-4/50291-9  0.36
2005 Winikoff SE, Zeh HJ, Richard D, Lotze MT. Handling and Storage of Cells and Sera: Practical Considerations Measuring Immunity: Basic Biology and Clinical Assessment. 233-236. DOI: 10.1016/B978-012455900-4/50281-6  0.36
2004 Vakkila J, DeMarco RA, Lotze MT. Imaging analysis of STAT1 and NF-κB translocation in dendritic cells at the single cell level Journal of Immunological Methods. 294: 123-134. PMID 15604022 DOI: 10.1016/j.jim.2004.09.007  1
2004 Vakkila J, Lotze MT. Inflammation and necrosis promote tumour growth Nature Reviews Immunology. 4: 641-648. PMID 15286730 DOI: 10.1038/nri1415  1
2004 Numasaki M, Lotze MT, Sasaki H. Interleukin-17 augments tumor necrosis factor-alpha-induced elaboration of proangiogenic factors from fibroblasts. Immunology Letters. 93: 39-43. PMID 15134897 DOI: 10.1016/j.imlet.2004.01.014  1
2004 Lotze MT, Papamichail M. A primer on cancer immunology and immunotherapy Cancer Immunology, Immunotherapy. 53: 135-138. PMID 14740175 DOI: 10.1007/s00262-003-0467-7  1
2004 Lotze MT, Rees RC. Identifying biomarkers and surrogates of tumors (cancer biometrics): correlation with immunotherapies and immune cells. Cancer Immunology, Immunotherapy : Cii. 53: 256-61. PMID 14735318 DOI: 10.1007/s00262-003-0487-3  1
2003 Kitagawa T, Iwazawa T, Robbins PD, Lotze MT, Tahara H. Advantages and limitations of particle-mediated transfection (gene gun) in cancer immuno-gene therapy using IL-10, IL-12 or B7-1 in murine tumor models Journal of Gene Medicine. 5: 958-965. PMID 14601133 DOI: 10.1002/jgm.441  1
2003 Son YI, Dallal RM, Lotze MT. Combined treatment with interleukin-18 and low-dose interleukin-2 induced regression of a murine sarcoma and memory response Journal of Immunotherapy. 26: 234-240. PMID 12806277 DOI: 10.1097/00002371-200305000-00007  1
2003 Nishioka Y, Wen H, Mitani K, Robbins PD, Lotze MT, Sone S, Tahara H. Differential effects of IL-12 on the generation of alloreactive CTL mediated by murine and human dendritic cells: a critical role for nitric oxide. Journal of Leukocyte Biology. 73: 621-9. PMID 12714577 DOI: 10.1189/jlb.0402205  1
2003 Redlinger RE, Mailliard RB, Lotze MT, Barksdale EM. Synergistic interleukin-18 and low-dose interleukin-2 promote regression of established murine neuroblastoma in vivo. Journal of Pediatric Surgery. 38: 301-7; discussion 30. PMID 12632339 DOI: 10.1053/jpsu.2003.50098  1
2003 Gao W, Kumar S, Lotze MT, Hanning C, Robbins PD, Gambotto A. Innate immunity mediated by the cytokine IL-1 homologue 4 (IL-1H4/IL-1F7) induces IL-12-dependent adaptive and profound antitumor immunity Journal of Immunology. 170: 107-113. PMID 12496389 DOI: 10.4049/jimmunol.170.1.107  1
2003 Hashimoto W, Tanaka F, Robbins PD, Taniguchi M, Okamura H, Lotze MT, Tahara H. Natural killer, but not natural killer T, cells play a necessary role in the promotion of an innate antitumor response induced by IL-18 International Journal of Cancer. 103: 508-513. PMID 12478667 DOI: 10.1002/ijc.10844  1
2003 Numasaki M, Fukushi JI, Ono M, Narula SK, Zavodny PJ, Kudo T, Robbins PD, Tahara H, Lotze MT. Interleukin-17 promotes angiogenesis and tumor growth Blood. 101: 2620-2627. PMID 12411307 DOI: 10.1182/blood-2002-05-1461  1
2002 Satoh Y, Esche C, Gambotto A, Shurin GV, Yurkovetsky ZR, Robbins PD, Watkins SC, Todo S, Herberman RB, Lotze MT, Shurin MR. Local administration of IL-12-transfected dendritic cells induces antitumor immune responses to colon adenocarcinoma in the liver in mice Journal of Experimental Therapeutics and Oncology. 2: 337-349. PMID 12440225 DOI: 10.1046/j.1359-4117.2002.01050.x  1
2002 Tanaka F, Hashimoto W, Robbins PD, Lotze MT, Tahara H. Therapeutic and specific antitumor immunity induced by co-administration of immature dendritic cells and adenoviral vector expressing biologically active IL-18 Gene Therapy. 9: 1480-1486. PMID 12378411 DOI: 10.1038/sj.gt.3301827  1
2002 Lotze MT, Kost TA. Viruses as gene delivery vectors: Application to gene function, target validation, and assay development Cancer Gene Therapy. 9: 692-699. PMID 12136431 DOI: 10.1038/sj.cgt.7700493  1
2002 Kumar S, Hanning CR, Brigham-Burke MR, Rieman DJ, Lehr R, Khandekar S, Kirkpatrick RB, Scott GF, Lee JC, Lynch FJ, Gao W, Gambotto A, Lotze MT. Interleukin-1F7B (IL-1H4/IL-1F7) is processed by caspase-1 and mature IL-1F7B binds to the IL-18 receptor but does not induce IFN-gamma production. Cytokine. 18: 61-71. PMID 12096920 DOI: 10.1006/cyto.2002.0873  1
2002 Jonak ZL, Trulli S, Maier C, McCabe FL, Kirkpatrick R, Johanson K, Ho YS, Elefante L, Chen YJ, Herzyk D, Lotze MT, Johnson RK. High-dose recombinant interleukin-18 induces an effective Th1 immune response to murine MOPC-315 plasmacytoma. Journal of Immunotherapy (Hagerstown, Md. : 1997). 25: S20-7. PMID 12048347 DOI: 10.1097/00002371-200203001-00004  1
2002 Lotze MT, Tahara H, Okamura H. Interleukin-18 as a novel, distinct, and distant member of the interleukin-1 family promoting development of the adaptive immune response: The interleukin-18 issue of the Journal of Immunotherapy Journal of Immunotherapy. 25. PMID 12048344 DOI: 10.1097/00002371-200203001-00001  1
2001 Shimizu T, Berhanu A, Redlinger RE, Watkins S, Lotze MT, Barksdale EM. Interleukin-12 transduced dendritic cells induce regression of established murine neuroblastoma. Journal of Pediatric Surgery. 36: 1285-92. PMID 11479878 DOI: 10.1053/jpsu.2001.25796  1
2001 Won Ki Kang, Park C, Hyunah Lee Yoon, Won Seog Kim, Yoon SS, Lee MH, Park K, Kim K, Hyun Sik Jeong, Kim JA, Nam SJ, Yang JH, Son YI, Baek CH, Han J, ... ... Lotze MT, et al. Interleukin 12 gene therapy of cancer by peritumoral injection of transduced autologous fibroblasts: Outcome of a phase I study Human Gene Therapy. 12: 671-684. PMID 11426466 DOI: 10.1089/104303401300057388  1
2000 Dallal RM, Lotze MT. The dendritic cell and human cancer vaccines Current Opinion in Immunology. 12: 583-588. PMID 11007363 DOI: 10.1016/S0952-7915(00)00146-1  1
2000 Agha-Mohammadi S, Lotze MT. Regulatable systems: Applications in gene therapy and replicating viruses Journal of Clinical Investigation. 105: 1177-1183. PMID 10791990 DOI: 10.1172/JCI10027  1
2000 Agha-Mohammadi S, Lotze MT. Immunomodulation of cancer: Potential use of selectively replicating agents Journal of Clinical Investigation. 105: 1173-1176. PMID 10791989 DOI: 10.1172/JCI10026  1
2000 Weigel TL, Lotze MT, Kim PK, Amoscato AA, Luketich JD, Odoux C. Paclitaxel-induced apoptosis in non-small cell lung cancer cell lines is associated with increased caspase-3 activity Journal of Thoracic and Cardiovascular Surgery. 119: 795-803. PMID 10733772 DOI: 10.1016/S0022-5223(00)70016-X  1
2000 Hiroishi K, Tüting T, Lotze MT. IFN-α-expressing tumor cells enhance generation and promote survival of tumor-specific CTLs Journal of Immunology. 164: 567-572. PMID 10623796 DOI: 10.4049/JIMMUNOL.164.2.567  1
1999 Lotze MT. In vivo veritas Clinical Immunology. 93: 1-4. PMID 10497005 DOI: 10.1006/clim.1999.4786  1
1999 McMasters KM, Sondak VK, Lotze MT, Ross MI. Recent advances in melanoma staging and therapy Annals of Surgical Oncology. 6: 467-475. PMID 10458685 DOI: 10.1007/s10434-999-0467-8  1
1999 Lotze MT. Not just an antigen-presenting cell: 5th International Symposium on Dendritic Cells in Fundamental and Clinical Immunology Journal of Leukocyte Biology. 66: 195-200. PMID 10449153 DOI: 10.1002/JLB.66.2.195  1
1999 Tanaka F, Hirao M, Lotze MT. Delivery of dendritic cells to sites of immune reactivity Clinical Immunology Newsletter. 19: 128-131. DOI: 10.1016/S0197-1859(00)87086-7  1
1998 Shurin GV, Gerein V, Lotze MT, Barksdale EM. Apoptosis induced in T cells by human neuroblastoma cells: role of Fas ligand. Natural Immunity. 16: 263-74. PMID 11061594 DOI: 10.1159/000069452  1
1998 Shurin MR, Esche C, Lotze MT. FLT3: Receptor and ligand. Biology and potential clinical application Cytokine and Growth Factor Reviews. 9: 37-48. PMID 9720755 DOI: 10.1016/S1359-6101(97)00035-X  1
1998 Vu HN, Jenkins FW, Swerdlow SH, Locker J, Lotze MT. Pleural effusion as the presentation for primary effusion lymphoma Surgery. 123: 589-591. PMID 9591015 DOI: 10.1067/msy.1998.88087  1
1998 Finn OJ, Lotze MT. Introduction: Third Keystone Symposium on Cellular Immunology and the Immunotherapy of Cancer Journal of Immunotherapy. 21: 114-118. PMID 9551362 DOI: 10.1097/00002371-199803000-00004  1
1998 Maeurer MJ, Lotze MT. Interleukin-7 (IL-7) knockout mice. Implications for lymphopoiesis and organ-specific immunity International Reviews of Immunology. 16: 309-322. PMID 9505193 DOI: 10.3109/08830189809042999  1
1997 Tüting T, Storkus WJ, Lotze MT. Gene-based strategies for the immunotherapy of cancer Journal of Molecular Medicine. 75: 478-491. PMID 9253711 DOI: 10.1007/s001090050133  1
1997 Lotze MT. Getting to the source: dendritic cells as therapeutic reagents for the treatment of patients with cancer Annals of Surgery. 226: 1-5. PMID 9242331 DOI: 10.1097/00000658-199707000-00001  1
1997 Maeurer MJ, Lotze MT. Tumor recognition by the cellular immune dystem: New aspects of tumor immunology International Reviews of Immunology. 14: 97-132. PMID 9131383 DOI: 10.3109/08830189709116848  1
1996 Rosenberg SA, Blaese RM, Brenner MK, Deisseroth AB, Ledley FD, Lotze MT, Wilson JM, Nabel GJ, Cornetta K, Economou JS, Freeman SM, Riddell SR, Oldfield E, Gansbacher B, Dunbar C, et al. Human gene marker/therapy clinical protocols. Human Gene Therapy. 7: 1621-47. PMID 8864763 DOI: 10.1089/hum.1996.7.13-1621  1
1996 Elder EM, Lotze MT, Whiteside TL. Successful culture and selection of cytokine gene-modified human dermal fibroblasts for the biologic therapy of patients with cancer. Human Gene Therapy. 7: 479-87. PMID 8800742 DOI: 10.1089/hum.1996.7.4-479  1
1996 Evans CH, Robbins PD, Ghivizzani SC, Herndon JH, Kang R, Bahnson AB, Barranger JA, Elders EM, Gay S, Tomaino MM, Wasko MC, Watkins SC, Whiteside TL, Glorioso JC, Lotze MT, et al. Clinical trial to assess the safety, feasibility, and efficacy of transferring a potentially anti-arthritic cytokine gene to human joints with rheumatoid arthritis. Human Gene Therapy. 7: 1261-80. PMID 8793551 DOI: 10.1089/hum.1996.7.10-1261  1
1996 Leder GH, Oppenheim M, Rosenstein M, Shah N, Hoffman R, Lotze MT, Beger HG. Inhibition of nitric oxide synthesis does not improve interleukin-2-mediated antitumor effects in vivo. European Surgical Research. EuropäIsche Chirurgische Forschung. Recherches Chirurgicales EuropéEnnes. 28: 167-78. PMID 8738527 DOI: 10.1159/000129455  1
1996 Goydos JS, Elder E, Whiteside TL, Finn OJ, Lotze MT. A phase I trial of a synthetic mucin peptide vaccine: Induction of specific immune reactivity in patients with adenocarcinoma Journal of Surgical Research. 63: 298-304. PMID 8667619 DOI: 10.1006/jsre.1996.0264  1
1996 Mayordomo JI, Loftus DJ, Sakamoto H, De Cesare CM, Appasamy PM, Lotze MT, Storkus WJ, Appella E, DeLeo AB. Therapy of murine tumors with p53 wild-type and mutant sequence peptide-based vaccines Journal of Experimental Medicine. 183: 1357-1365. PMID 8666894 DOI: 10.1084/jem.183.4.1357  1
1996 Zitvogel L, Robbins PD, Storkus WJ, Clarke MR, Maeurer MJ, Campbell RL, Davis CG, Tahara H, Schreiber RD, Lotze MT. Interleukin-12 and B7.1 co-stimulation cooperate in the induction of effective antitumor immunity and therapy of established tumors. European Journal of Immunology. 26: 1335-41. PMID 8647214 DOI: 10.1002/eji.1830260624  1
1996 Maeurer MJ, Storkus WJ, Kirkwood JM, Lotze MT. New treatment options for patients with melanoma: Review of melanoma-derived T-cell epitope-based peptide vaccines Melanoma Research. 6: 11-24. PMID 8640065 DOI: 10.1097/00008390-199602000-00003  1
1995 Zitvogel L, Lotze MT. Role of interleukin-12 (IL12) as an anti-tumour agent: experimental biology and clinical application. Research in Immunology. 146: 628-38. PMID 8839171 DOI: 10.1016/0923-2494(96)83041-0  1
1995 Maeurer MJ, Martin DM, Storkus WJ, Lotze MT. TCR usage in CTLs recognizing melanoma/melanocyte antigens Immunology Today. 16: 603-604. PMID 8579754 DOI: 10.1016/0167-5699(95)80084-0  1
1995 Pappo I, Tahara H, Robbins PD, Gately MK, Wolf SF, Barnea A, Lotze MT. Administration of systemic or local interleukin-2 enhances the anti-tumor effects of interleukin-12 gene therapy. The Journal of Surgical Research. 58: 218-26. PMID 7861776 DOI: 10.1006/jsre.1995.1034  1
1995 Castelli C, Storkus WJ, Maeurer MJ, Martin DM, Huang EC, Pramanik BN, Nagabhushan TL, Parmiani G, Lotze MT. Mass spectrometric identification of a naturally processed melanoma peptide recognized by CD8+ cytotoxic T lymphocytes. The Journal of Experimental Medicine. 181: 363-8. PMID 7807017 DOI: 10.1084/jem.181.1.363  1
1995 Suzuki T, Tahara H, Narula S, Moore KW, Robbins PD, Lotze MT. Viral interleukin 10 (IL-10), the human herpes virus 4 cellular IL-10 homologue, induces local anergy to allogeneic and syngeneic tumors. The Journal of Experimental Medicine. 182: 477-86. PMID 7629507 DOI: 10.1084/jem.182.2.477  1
1995 Suminami Y, Elder EM, Lotze MT, Whiteside TL. In situ interleukin-4 gene expression in cancer patients treated with genetically modified tumor vaccine. Journal of Immunotherapy With Emphasis On Tumor Immunology : Official Journal of the Society For Biological Therapy. 17: 238-48. PMID 7582260 DOI: 10.1097/00002371-199505000-00006  1
1994 Oppenheim MH, Lotze MT. Interleukin-2: solid-tumor therapy. Oncology. 51: 154-69. PMID 8196899 DOI: 10.1159/000227330  1
1994 Zeh HJ, Leder GH, Lotze MT, Salter RD, Tector M, Stuber G, Modrow S, Storkus WJ. Flow-cytometric determination of peptide-class I complex formation. Identification of p53 peptides that bind to HLA-A2. Human Immunology. 39: 79-86. PMID 8175386 DOI: 10.1016/0198-8859(94)90105-8  0.36
1993 Wong HL, Costa GL, Lotze MT, Wahl SM. Interleukin (IL) 4 differentially regulates monocyte IL-1 family gene expression and synthesis in vitro and in vivo Journal of Experimental Medicine. 177: 775-781. PMID 8436908  1
1993 Miller DL, Lotze MT. A plea for a standard standard Radiology. 188: 19-20. PMID 8390068 DOI: 10.1148/radiology.188.1.8390068  1
1993 Kawakami Y, Haas GP, Lotze MT. Expansion of tumor-infiltrating lymphocytes from human tumors using the T-cell growth factors interleukin-2 and interleukin-4 Journal of Immunotherapy. 14: 336-347. PMID 8280717 DOI: 10.1097/00002371-199311000-00014  1
1992 Lotze MT. T-cell growth factors and the treatment of patients with cancer Clinical Immunology and Immunopathology. 62. PMID 1728987 DOI: 10.1016/0090-1229(92)90040-U  1
1992 Lotze MT, Zeh HJ, Elder EM, Cai Q, Pippin BA, Rosenstein MM, Whiteside TL, Herberman R. Use of T-cell growth factors (interleukins 2, 4, 7, 10, and 12) in the evaluation of T-cell reactivity to melanoma. Journal of Immunotherapy : Official Journal of the Society For Biological Therapy. 12: 212-7. PMID 1359903 DOI: 10.1097/00002371-199210000-00015  0.36
1991 Culver K, Cornetta K, Morgan R, Morecki S, Aebersold P, Kasid A, Lotze M, Rosenberg SA, Anderson WF, Blaese RM. Lymphocytes as cellular vehicles for gene therapy in mouse and man. Proceedings of the National Academy of Sciences of the United States of America. 88: 3155-9. PMID 2014235 DOI: 10.1073/pnas.88.8.3155  1
1991 Lotze MT. Trials and tribulations: the cost of developing gene therapies. Faseb Journal : Official Publication of the Federation of American Societies For Experimental Biology. 5: 3013-4. PMID 1743433 DOI: 10.1096/fasebj.5.15.1743433  1
1991 Stötter H, Lotze MT. Human Lymphokine-Activated Killer Cell Activity: Role of IL-2, IL-4, and IL-7 Archives of Surgery. 126: 1525-1530. PMID 1726819 DOI: 10.1001/archsurg.1991.01410360099017  1
1990 Kasid A, Morecki S, Aebersold P, Cornetta K, Culver K, Freeman S, Director E, Lotze MT, Michael Blaese R, Anderson WF, Rosenberg SA. Human gene transfer: Characterization of human tumor-infiltrating lymphocytes as vehicles for retroviral-mediated gene transfer in man Proceedings of the National Academy of Sciences of the United States of America. 87: 473-477. PMID 2404283 DOI: 10.1073/pnas.87.1.473  1
1990 Bock SN, Lee RE, Fisher B, Rubin JT, Schwartzentruber DJ, Wei JP, Callender DPE, Yang JC, Lotze MT, Pizzo PA, Rosenberg SA. A prospective randomized trial evaluating prophylactic antibiotics to prevent triple-lumen catheter-related sepsis in patients treated with immunotherapy Journal of Clinical Oncology. 8: 161-169. PMID 2404087 DOI: 10.1200/jco.1990.8.1.161  1
1990 Rosenberg SA, Aebersold P, Cornetta K, Kasid A, Morgan RA, Moen R, Karson EM, Lotze MT, Yang JC, Topalian SL, Merino MJ, Culver K, Miller AD, Blaese RM, Anderson WF. Gene transfer into humans - Immunotherapy of patients with advanced melanoma, using tumor-infiltrating lymphocytes modified by retroviral gene transduction New England Journal of Medicine. 323: 570-578. PMID 2381442 DOI: 10.1056/NEJM199008303230904  1
1990 Ward B, McGarvey C, Lotze MT. Excellent Shoulder Function Is Attainable After Partial or Total Scapulectomy: Analysis at Prolonged Follow-up Archives of Surgery. 125: 537-542. PMID 2322121 DOI: 10.1001/archsurg.1990.01410160125024  1
1990 Lotze MT, Custer MC, Bolton ES, Wiebke EA, Kawakami Y, Rosenberg SA. Mechanisms of immunologic antitumor therapy: lessons from the laboratory and clinical applications. Human Immunology. 28: 198-207. PMID 2190952 DOI: 10.1016/0198-8859(90)90020-P  1
1990 Custer MC, Lotze MT. A biologic assay for IL-4 rapid fluorescence assay for IL-4 detection in supernatants and serum Journal of Immunological Methods. 128: 109-117. PMID 2139081 DOI: 10.1016/0022-1759(90)90469-C  1
1988 Kawakami Y, Rosenberg SA, Lotze MT. Interleukin 4 promotes the growth of tumor-infiltrating lymphocytes cytotoxic for human autologous melanoma Journal of Experimental Medicine. 168: 2183-2191. PMID 3264324 DOI: 10.1084/jem.168.6.2183  1
1988 Schwartzentruber D, Lotze MT, Rosenberg SA. Colonic perforation: An unusual complication of therapy with high-dose interleukin-2 Cancer. 62: 2350-2353. PMID 3263182 DOI: 10.1002/1097-0142(19881201)62:11<2350::AID-CNCR2820621116>3.0.CO;2-S  1
1988 Ognibene FP, Rosenberg SA, Lotze M, Skibber J, Parker MM, Shelhamer JH, Parrillo JE. Interleukin-2 administration causes reversible hemodynamic changes and left ventricular dysfunction similar to those seen in septic shock Chest. 94: 750-754. PMID 3262487 DOI: 10.1378/chest.94.4.750  1
1988 Topalian SL, Solomon D, Avis FP, Chang AE, Freerksen DL, Linehan WM, Lotze MT, Robertson CN, Seipp CA, Simon P, Simpson CG, Rosenberg SA. Immunotherapy of patients with advanced cancer using tumor-infiltrating lymphocytes and recombinant interleukin-2: A pilot study Journal of Clinical Oncology. 6: 839-853. PMID 3259261 DOI: 10.1200/JCO.1988.6.5.839  1
1988 Jablons DM, Lotze MT. Derivation of cells with lytic activity against fresh and cultured tumors from human bone marrow Journal of Surgical Research. 44: 404-416. PMID 3258943 DOI: 10.1016/0022-4804(88)90183-7  1
1988 Lotze MT, Rosenberg SA. The immunologic treatment of cancer Ca-a Cancer Journal For Clinicians. 38: 68-94. PMID 2450624 DOI: 10.3322/canjclin.38.2.68  1
1986 Lotze MT, Carrasquillo JA, Weinstein JN, Bryant GJ, Perentesis P, Reynolds JC, Matis LA, Eger RR, Keenan AM, Hellström I. Monoclonal antibody imaging of human melanoma. Radioimmunodetection by subcutaneous or systemic injection Annals of Surgery. 204: 223-235. PMID 3753057 DOI: 10.1097/00000658-198609000-00002  1
1986 Lotze MT, Custer MC, Rosenberg SA. Intraperitoneal Administration of Interleukin-2 in Patients With Cancer Archives of Surgery. 121: 1373-1379. PMID 3491595 DOI: 10.1001/archsurg.1986.01400120019002  1
1986 Lotze MT, Rosenberg SA. Results of clinical trials with the administration of interleukin 2 and adoptive immunotherapy with activated cells in patients with cancer Immunobiology. 172: 420-437. PMID 3100435 DOI: 10.1016/S0171-2985(86)80122-X  1
1986 Lotze MT. Surgical considerations in the diagnosis and management of AIDS Aids Research. 2: 141-148. PMID 3013222 DOI: 10.1089/aid.1.1986.2.141  1
1985 Lotze MT, H. Sugarbaker P. Femoral artery based myocutaneous flap for hemipelvectomy closure: Amputation after failed limb-sparing surgery and radiotherapy The American Journal of Surgery. 150: 625-629. PMID 4061747 DOI: 10.1016/0002-9610(85)90451-9  1
1984 Lotze MT, Rosenberg SA. In vivo use of cytokines Clinical Immunology Newsletter. 5: 116-120. DOI: 10.1016/S0197-1859(84)80031-X  1
1981 Lotze MT, Duncan MA, Gerber LH, Woltering EA, Rosenberg SA. Early versus delayed shoulder motion following axillary dissection: a randomized prospective study. Annals of Surgery. 193: 288-95. PMID 7011221 DOI: 10.1097/00000658-198103000-00007  1
1981 Bias WB, Hsu SH, Pollard MK, Harvey J, Lotze MT, Arnett FC, Stevens MB. HLA-DR characterization of a Chippewa Indian subpopulation with high prevalence of rheumatoid arthritis Human Immunology. 2: 155-163. PMID 6455397 DOI: 10.1016/0198-8859(81)90062-8  1
Show low-probability matches.